ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Laverock Therapeutics Limited

Laverock Therapeutics Limited is an active company incorporated on 13 July 2021 with the registered office located in Eastleigh, Hampshire. Laverock Therapeutics Limited was registered 4 years ago.
Status
Active
Active since incorporation
Company No
13508159
Private limited company
Age
4 years
Incorporated 13 July 2021
Size
Small
Balance sheet is under £7.5M
Under 50 employees
Confirmation
Submitted
Dated 12 July 2025 (3 months ago)
Next confirmation dated 12 July 2026
Due by 26 July 2026 (8 months remaining)
Last change occurred 3 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Small
Next accounts for period 31 December 2025
Due by 30 September 2026 (11 months remaining)
Address
C/O Xeinadin First Floor Secure House
Lulworth Close
Chandler's Ford
SO53 3TL
United Kingdom
Address changed on 2 Aug 2024 (1 year 3 months ago)
Previous address was , 3 Victoria Place Love Lane, Romsey, SO51 8DE, England
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
8
Shareholders
79
Controllers (PSC)
1
Director • Investment Director • British • Lives in England • Born in Sep 1971
Director • American • Lives in United States • Born in Oct 1967
Director • Israeli • Lives in England • Born in Jan 1982
Director • British • Lives in UK • Born in Mar 1955
Director • Ceo • British • Lives in Scotland • Born in Dec 1966
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Tagomics Ltd
Elizabeth Edmonds is a mutual person.
Active
Censo Biotechnologies Ltd
Dr David Charles Venables is a mutual person.
Active
Klein-Edmonds Associates Limited
Elizabeth Edmonds is a mutual person.
Dissolved
Biomelior Services Ltd
Dr David Charles Venables is a mutual person.
Liquidation
Financials
Net Assets, Total Assets & Total Liabilities (2022–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
£3.46M
Decreased by £5.35M (-61%)
Turnover
Unreported
Same as previous period
Employees
29
Increased by 14 (+93%)
Total Assets
£5.95M
Decreased by £4.28M (-42%)
Total Liabilities
-£921K
Decreased by £75K (-8%)
Net Assets
£5.03M
Decreased by £4.2M (-45%)
Debt Ratio (%)
15%
Increased by 5.73% (+59%)
Latest Activity
Confirmation Submitted
3 Months Ago on 17 Jul 2025
Sarah Noonberg Appointed
7 Months Ago on 4 Apr 2025
Small Accounts Submitted
7 Months Ago on 31 Mar 2025
Susan Elizabeth Foden Resigned
1 Year Ago on 2 Nov 2024
Registered Address Changed
1 Year 3 Months Ago on 2 Aug 2024
Anne-Marie Louise Soeiro Elsley Appointed
1 Year 3 Months Ago on 19 Jul 2024
Rosheen Caw Resigned
1 Year 3 Months Ago on 19 Jul 2024
Confirmation Submitted
1 Year 3 Months Ago on 19 Jul 2024
Small Accounts Submitted
1 Year 6 Months Ago on 24 Apr 2024
Tropic Biosciences Uk Limited (PSC) Resigned
2 Years 1 Month Ago on 29 Sep 2023
Get Credit Report
Discover Laverock Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Statement of capital following an allotment of shares on 21 July 2025
Submitted on 21 Jul 2025
Confirmation statement made on 12 July 2025 with updates
Submitted on 17 Jul 2025
Statement of capital following an allotment of shares on 27 June 2025
Submitted on 9 Jul 2025
Appointment of Sarah Noonberg as a director on 4 April 2025
Submitted on 19 Jun 2025
Statement of capital following an allotment of shares on 10 June 2025
Submitted on 10 Jun 2025
Memorandum and Articles of Association
Submitted on 8 Apr 2025
Resolutions
Submitted on 8 Apr 2025
Statement of capital following an allotment of shares on 31 March 2025
Submitted on 8 Apr 2025
Accounts for a small company made up to 31 December 2024
Submitted on 31 Mar 2025
Termination of appointment of Susan Elizabeth Foden as a director on 2 November 2024
Submitted on 5 Mar 2025
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year